2nd European Clinical Data Disclosure Summit

Faculty

Stephane Gilles

R&D IS - Project Management

SANOFI-AVENTIS

Susanne Jena

Project Manager

German Clinical Trials Register

Merete Joergensen, MSc, MBA

Project Director, Public Access to Clinical Trials

NOVO NORDISK A/S

Monica Mehta

Director, Regulatory Affairs

Genzyme Corporation

Rob Middel

Director of Global Operations, Quality Management

Johnson & Johnson Pharmaceuticals Research & Development

Paul Ngai

Principal

180 GLOBAL CONSULTING, LLC

Detlef Niese, MD, PhD

Head, External Affairs, Global Development

NOVARTIS

Deven Parmar

Vice President, Clinical Research

WOCKHARDT

Jacqueline Sayers

Quality Projects Manager

ROCHE PRODUCTS LIMITED

Erica F. Schirmer

Global Operations Lead, Clinical Registry

Johnson & Johnson Pharmaceuticals Research & Development

Pat Teden, MBA

Principal

TEDEN CONSULTING LLC.

Thomas Wicks

Business Development Manager

INTRASPHERE TECHNOLOGIES

Industry experts discuss the need for change in the submission process for Clinical Trial Approval and Results to Ensure Maximum Compliance and Efficiency

An In-Depth Look at EudraCT Version 8; What Changes are Included in the New Version as Well as What Changes are Anticipated for Version 9

2nd European Clinical Data Disclosure Summit

Faculty

Sponsors